Relationship between HTPR and END in acute non-cardiogenic cerebral infarction patients after thrombolytic therapy
10.3969/j.issn.1009-0126.2017.09.008
- VernacularTitle:抗血小板治疗后血小板高反应性与急性非心源性脑梗死早期神经功能恶化的关系
- Author:
Tingting GUO
;
Zhao HUANG
;
Yujie WANG
- Keywords:
platelet aggregation inhibitors;
thrombocytosis;
brain infarction;
aspirin;
platelet aggregation;
ROC curve
- From:
Chinese Journal of Geriatric Heart Brain and Vessel Diseases
2017;19(9):926-929
- CountryChina
- Language:Chinese
-
Abstract:
Objective To study the relationship between high on-treatment platelet reactivity (HTPR) and early neurological deterioration (END) in acute non-cardiogenic cerebral infarction patients.Methods Two hundred and fifteen acute non-cardiogenic cerebral infarction patients were divided into END group (n=55) and EDD-free group (n=160).The patients were given oral aspirin (300 mg daily) on the day after admission,and fasting blood samples were taken at 6-24 h after the first dose of aspirin.Their platelet aggregative function (PAGT) was assayed with ADP to detect the platelet responsiveness to aspirin.The incidence of HTPR was compared between the two groups.The independent risk factors for END were analyzed by multivariate logistic regression analysis.The value of PAGT in predicting END was assessed according to its ROC curve.Results The incidence of HTRP was higher in END group than in END-free group (63.34％ vs 43.75％,P＜0.05).Multivariate logistic regression analysis showed that HTRP was an independent risk factor for acute non-cardiogenic cerebral infarction.The area under the ROC curve was 0.864 for PAGT in predicting acute non-cardiogenic cerebral infarction (95 ％ CI:0.806-0.922,P=0.000).Conclusion HTPR is closely related with END in acute non-cardiogenic cerebral infarction patients.
